InvestorsHub Logo
Followers 1879
Posts 137447
Boards Moderated 5
Alias Born 01/03/2007

Re: A deleted message

Monday, 01/11/2016 3:10:06 PM

Monday, January 11, 2016 3:10:06 PM

Post# of 1059
Pacific Biosciences initial Sequel orders very strong, says Piper Jaffray
Piper Jaffray analyst William Quirk said the 49 Sequels orders Pacific Biosciences reported for Q4 were above his projection of 10 orders and topped the 47 total orders he exepcted for this quarter through the second quarter of 2016. Also, commentary regarding a Sequel ramp in the second half of the year should not be surprising given management's past comments that Sequel volume will be constrained in the first half due to manufacturing and chip supply, Quirk said. The analyst keeps an Overweight rating and $9 price target on Pacific Bio shares

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PACB News